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SY
Trophic factors play an important role in the
development of neurons and glia. In order to
study the involvement of neurotrophins in
human cortical development, human fetal
parietal cortical tissue, obtained after early
elective abortions, was transplanted to cortical
cavities in immunosuppressed rats. Using in situ
hybridization it was demonstrated that nerve
growth factor, brain-derived neurotrophic fac-
tor and neurotrophin-3 mRNAs are expressed in
developing human cortical xenografts. We con-
clude that neurotrophins may play a role in
human cortical development and rat-derived
astroglial cells could be involved in establishing
reciprocal "permissive sites".
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INTRODUCTION
To achieve a better understanding of the
involvement of trophic factors in human cortical
development, studies of the rodent cortex need to
be supplemented with studies ofthe primate cortex.
As an alternative to non-human primates, human-to-
rat xenografts provide an interesting possibility
/2,5,14,15,25,30,38-41/. The procurement of tis-
sues atter early elective routine abortions has
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permitted studies ofhuman fetal CNS tissue grafted
to immunocompromised rodent hosts and of the
expression of different human genes and proteins.
Growth factors play an important role in survival
and differentiation in the CNS and the guiding/
targeting of nerve fiber growth. Nerve growth
factor (NGF) and other neurotrophins, brain-
derived neurotrophic factor (BDNF), neurotrophin-
3 (NT-3) and neurotrophin-4/5, are all present in
the brain, the highest levels of NGF, BDNF and
NT-3 mRNAs being found in the hippocampus
/1,6,12,24,31,42/. Neurotrophins are also expressed
in other brain areas, such as cerebral cortex, and
may have important functional roles in this brain
area, as shown in vitro and in vivo /3,4,10,13,17,20,
22,29,34,35/.
Recently, we demonstrated that human fetal
cortical tissue fragments survive grafting to cavities
ofthe rat brain/16/. These tissue fragments became
integrated with the host brain and formed reciprocal
nerve fiber connections /16/. The ingrowth or
outgrowth of nerve fibers seemed to occur at
specific sites, so called ’ermissive sites", probably
guided by trophic interactions /16/. The human
grafts significantly expressed angiotensinogen
mRNA and protein, indicating a role for this
neuropeptide precursor in cortical development
/18/. In a recent study we demonstrated BDNF
mRNA in developing rat cortex, grafted in oculo to
the anterior eye chamber /17/. The aim of the
present study was to observe whether the neuro-
trophin mRNAs (NGF, BDNF, NT-3) are expressed
in developing human cortical xenografts. We
showed that all three neurotrophins were found in
these grafts and rat-derived astroglial cells could be
involved in establishing reciprocal connections
between graft and host.
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MATERIALS AND METHODS
Grafting procedure
Grafting was performed as described in detail
previously /16,18/. Human fetal parietal cortical
fragments were recovered after first trimester (8.5-
9.5 weeks) abortions. Women admitted for elective
abortions, who had no prior knowledge of this
study, were informed of the aims of the study and
gave their consent. Anonymity was strictly
maintained. The abortions were performed
according to hospital routine, with low-pressure
vacutun aspiration and with approval by the
Regional Ethical Committee of the Karolinska
Institute. A cavity in the cortex (bregma: -1 to -2
laterally) of halothane anesthetized female Sprague
Dawley rats (B&K Laboratories AB, Sweden, 200-
220g, n=5) was made by gentle suction with a
modified glass pipette connected to an aspiration
pump. The cavity was filled with gelfoam
(Spongostan) soaked in Hanks’ balanced salt
solution (HBSS; Gibco). After 1-2 weeks, the
gelfoam was removed under anesthesia to expose
the cavity. Human cortical tissue pieces (1-2 mm3)
were placed at the bottom of the cavity and the
cavity closed with gelfoam soaked in HBSS. For
immtmosuppression all rats received daffy injections
of cyclosporine A (10 mg/kg; Sandoz) containing
vibramycin (2 mg/kg; Pfizer), starting the day
before grafting. The total number of grafts studied
was five.
In situ hybridization
At different times after grafting (16.5-34 weeks),
animals were sacrificed, their brains removed,
immediately frozen on dry ice, sectioned (14 tm)
with a cryostat (Leitz) and thawed onto slides
(ProbeOn
TM slides, Fisher Biotech, USA). In situ
hybridization was performed as described pre-
viously/19,44-46/. Oligonucleotides were labeled at
the 3" end with [ct-35S]dATP using terminal
deoxyfibonucleotidyl transferase (NEN, DuPont,
Sweden) and purified on nensorb columns (NEN).
Sections were hybridized at 42C overnight in a
humidified chamber with 0.1 ml per slide of the
hybridization solution [50% formamide, 4xSSC,
0.02% polyvinyl-pyrrolidone, 0.02% Ficoll, 0.02%
bovine serum albumin, 10% dextrane sulfate, 0.5
mg/ml sheared salmon sperm DNA, 1% sarcosyl
(N-lauroyl sarcosine), 0.02 M Na3PO4 (pH 7.0), 50
mM dithiotreitol] containing lxl07 CPM/ml probe.
Sections were subsequently rinse,d, washed four
times (15 min each) at 54C in lxSSC, cooled to
room temperature, dehydrated through 70%, 90%
and 99% ethanol and air dried. Sections were
dipped in Kodak NTB-2 photo emulsion (diluted
1:1 in water), exposed for 6 (truncated trkB) and 15
weeks (neurotrophins) at -20C, developed, fixed,
and lightly counterstained with cresyl violet.
Sections were analyzed using light and dark-field
microscopy (Nikon Microphot) and photographed
(Kodak Tmax-400). Slides were evaluated under
the dark field microscope and the signal estimated
using a semi-quantitative scale from 0-4.
The following antisense oligonucleotides were
used:
NGF, bp 464-513 (5"-CCT GC GTC CAC AGT
AAT GTT GCG GGT CTG CCC CGC CAC GCG
TGC AGC TAT)/43/; BDNF, bp 251-298 (5"-CTC
CAG AGT CCC ATG GGT CCG CAC ACC TGG
GTA GC CAA GCT GCC TTG)/33/; NT-3, bp
379-429 (CTC CAA GCA3 GGT GCT GTC GCT
CAG CAG GAC CCG CGG TGA ATT GTA GCG
TCT)/26/; rat specific truncated trkB, bp 723-767
(5"-ACA TGG GC AGG CAA GAG AAG CCC
TCC AGA AGC CCAAGA CCA GCA)/27/.
RESULTS
All neurotrophin oligonucleotides showed cross
reaction with rat and gave the expected hybridi-
zation signal in host rat hippocampus (Fig. 1, upper
panel). NGF mRNA was strongly expressed in
neurons in and around the host granule and
pyramidal cell layer ofhippocampus, BDNF mRNA
was found in neurons in the granule and pyramidal
cell layer of the hippocampal formation and NT-3
mRNA was seen in neurons ofthe granule cell layer
ofdentate gyms and in CA2 and medial CA1 areas.
All three neurotrophins were expressed in the
developing human cortical xenografts (Fig. 1,
middle and lower panel). Clear scattered areas of
NGF positive cells were detectable in the human
transplants. The NGF mRNA signal was lowest in
the younger grafts (16.5-20 weeks), reached a
JOURNAL OF NEURAL TRANSPLANTATION & PLASTICITYNI’IJR()TROPtlINS IN ltUMAN C()RTEX 259
NGF BDNF NT-3
e-
X
X
Expression of neurotrophin mRNAs in dentate gyms of the rat host hippocampus and in human cortical xenografts. The
oligonucleotides cross react with rat and reveal NGF mRNA expression in neurons (arrows) inside the host granule cell
layer of the dentate gyrus and in the hilus (left panel); BDNF mRNA expression in neurons in the granule (gr) cell layer
of the hippocampal formation (middle panel), and NT-3 mRNA expression in neurons of the granule cell layer of
dentate gyrus (right panel). In the human cortical xenografts clusters of cells were found expressing either NGF, BDNF
or NT-3 mRNAs. The pictures show examples of transplants taken 25 (NGF and NT-3) or 16.5 (BDNF) weeks
postgrafting. Bright field microscopy reveals specific localization of the silver grains over cresyl violet counterstained
cells (lowest panel). Bar (from left to right) 90, 140, 30 tm (NGF); 20, 140, 20 tm (BDNF); 70, 140, 25m (NT-3).
maximum at week 25, and decreased again in the
older grafts (32-34 weeks) (Table 1). A strong
patchy expression ofBDNF mRNA was seen in the
human cortical grafts, qe signal for BDNF mRNA
was highest in the youngest graft (16.5 weeks),
slightly decreased thereafter, reaching a moderate
expression in the older grafts (Table 1). NT-3
mRNA was Ibund in the gratis in a patchy pattern.
The signal for NT-3 mRNA peaked at week 25
(Table l).
In situ hybridization for rat tnmcated trkB
receptor mRNA showed a strong signal over the
host cortex (Fig. 2a,b). The gratis partly revealed
higher background but did not show a specific
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TABLE
Quantitative expression of nerve growth factor (NGF), brain-derived neurotrophic factor
(BDNF) and neurotrophin-3 (NT-3) mRNAs in five different human cortical grafts, as
evaluated by in situ hybridization
graft fetal age gratis
# [weeks] [weeks]
mRNA expression in the grafts*
NGF BDNF NT-3
1 9.5 16.5 +(+) ++++ +
2 9 20 ++ +(+) ++
3 9.5 25 +++(+) ++ +++(+)
4 8.5 32 +(+) +(+) +
5 8.5 34 (+) +++ +(+)
* The intensity of labeling was selniquanlilatively graded: + low, ++ medium, 4++ strong, and
very strong.
Fig. 2: High levels of expression of rat truncated trkB receptor mRNA are found in the rat host cortex (ctx), while the human
transplants (tp) have a somewhat higher background but are negative (a, b). Somewhat stronger signals are found close
to the graft-host interface (a, b). The box in Fig. a represents the area depicted at higher magnification in Fig. b. In a few
areas a strong signal is found representing "permissive sites" (large arrows, c, d). Bright field microscopy reveals
specific localization (small arrows) of silver grains over cresyl violet counterstained cells (d). Bar 240 tm (a), 100
(b), 150 tm (c), 50 tm (d).
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signal (Fig. 2a-d). Often the hybridization signal
was increased at the graft-host interface (Fig. 2b).
In a few cases a strong signal was found in rat-
derived cells, possibly in areas where nerve fibers
entered the transplant (Fig. 2c,d).
DISCUSSION
This study is an extension of our previous
studies in which human-to-rat cortical xenografts
/16,18/ and rat cortex in oculo grafts /17/ were
characterized. Briefly, the majority of the grafts
survived, became integrated with the rat host cortex
and formed reciprocal nerve fiber connections.
Specific ’permissive sites" seem to be involved in
this nerve fiber growth from graft to host and from
host to graft. The present study demonstrates that
NGF, BDNF and NT-3 mRNAs were expressed in
the developing human cortical xenografis.
NGF, BDNF and NT-3 cross reacted with rat
and gave the expected pattern of expression in the
rat hippocampus/9,12,31/. The probe for truncated
trkB receptor gave strong signals all over the rat
host brain, especially in rat cortex/19/. The positive
cells in the grafts expressing the neurotrophins and
their receptors were identified using bright field
microscopy, showing the silver grains to be located
over cresyl violet counterstained cells.
Several studies have indicated a role for
neurotrophins in cortical development in the rat.
Using in situ hybridization, BNDF mRNA was
found in several cortical areas (frontal, parieto-
temporal, cingulate and piriform) in the developing
rat from 2 weeks of age and thereafter/10/and in
prefrontal cortex of fetal and adult monkeys/20/.
Exogenous NGF affected the development of
graRed cortex cerebri /8/ and BDNF, and much less
potently NT-3, regulated neuropeptide expression
in cultured cerebral cortical neurons/29/. Castrrn et
al. /3/ demonstrated that physiological stimuli
(visual input changes) can regulate BDNF and trkB
mRNAs in the visual cortex. Neurotrophins also
seem to play an important role in glutamate-
mediated excitotoxicity in cortical neurons/22,33,
34/. Recently, we reported/17/that BDNF mRNA
as well as trkB receptor mRNAs were expressed in
rat cortex cerebri grafted to the anterior chamber of
the eye. BDNF mRNA expression was increased
compared to adult cortices in single grafts and
downregulated to near control levels by a
compensating second graft, indicating trophic
interactions/17/. The present study extends these
reports, and describes that all three analyzed
neurotrophins, NGF, BDNF and NT-3, are
expressed in the human cortical xenograRs, likely
playing important roles during development.
Indeed, a recent report showed that BDNF is
required for activity-dependent survival of cortical
neurons/13/. Since it was not easy to obtain several
grafts ofthe same age in this study, the different age
data need to be carefully interpreted. It might be
possible that the different levels of mRNA
expression do not represent normal developmentally
regulated mRNA expression, but are merely a
reflection of intra-transplantation or intra-donor
variability.
Earlier studies of similar graRs suggested that
most cells in our human grafts were immature/18/.
Recently, we reported that the mRNA for a
neuropeptide precursor, human angiotensinogen,
was expressed mainly in immature protoplasmatic
astrocytes in human cortical grafts/18/. As we were
not able to use non-radioactive in situ hybridization
combined with glial immunomarkers, we cannot
determine whether the neurotrophins are expressed
in immature neurons and/or glial cells as well.
However, since the localization of neurotrophins in
glial cells has not been demonstrated by in situ
hybridization in vivo, we suggest that the
neurotrophin mRNAs are expressed in immature
neurons in the human cortical grafts. This is in
agreement with Miranda et al. /28/, who reported
that NGF and BDNF and more rarely NT-3 mRNAs
were expressed in the developing rat cerebral
cortex.
The neurotrophins bind with high affinity to
receptors encoded by members of the trk family of
proto-oncogenes/6,7,32/. The trk-related gene trkB
encodes a high-affinity signal transducing compo-
nent, having high affinity for both BDNF and NT-3
/36,37/. The full-length trkB contains a tyrosine
kinase domain, while truncated trkB lacks an
intracellular signal-transducing domain /21,27/. In
the CNS, the full-length trkB mRNA is pre-
dominantly expressed in neurons, while expression
of truncated trkB is predominantly found in glial
cells/11,21,44/. Miranda et al. /28/ recently demon-
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strated that the trkB receptor mRNA is expressed in
the developing rat cerebral cortex, and is co-
expressed with different neurotrophins. Kumar et
al. /23/reported that trkB is present in astrocytes
and upregulated by NGF, suggesting a role in
normal glial function. In our study, truncated trkB
mRNA expression was otten very strong in areas at
the graft-host interface to the cortical grafts
indicating that rat astroglial processes are involved.
We have also observed a similar phenomenon in
intraoculo rat cortical transplants/17/. The present
data indicate that glial processes and the high
affinity trkB receptor might be involved in neuronal
and glial communication at the graft-host border.
"Permissive sites" seem to be responsible for
establishing reciprocal newe fiber connections.
Several cases of such ’])ermissive sites" were found
in our human cortical gratts and nerve fibers labeled
with human-specific neurofilament antibody entered
such sites (for details see/16,18/). We report now
that these ’permissive sites" appear to contain rat-
derived cells expressing the truncated trkB receptor
mRNA. These cells seem to form an entry for the
ingrowth (or outgrowth) or nerve fibers, starting
from a specific point at the host-graft interface. We
suggest that these cells are rat astrocytes, because
truncated trkB is predominantly found in glial cells
and neu.rons, while the expression of full length trkB
is restricted to neurons. At the ’permissive sites", it
might be possible that astroglial processes are
necessary for guiding/targeting nerve fiber growth
and that neurotrophins could play a role in this
process.
lis study shows that mRNAs for NGF, BDNF
and NT-3 are expressed in developing human
cortical gratis. We conclude that neurotrophins may
play a role during development and nerve fiber
growth in the human cortex, and rat-derived
astroglia could be involved in establishing reciprocal
connections.
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